CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells — Matthias Braun (2020) | RDL Network
Matthias Braun, Indrajit Das, Amelia Roman Aguilera, Ashmitha Sundarrajan, Dillon Corvino, Gabrielle Kelly, Frank Vari, Ailin Lepletier, Sally‐Ann Pearson, Jason Madore, Sophie Krumeich, Sébastien Jacquelin, Maike Effern, Mika Casey, Kyohei Nakamura, Eun Young Seo, André Veillette, Michael Hölzel, Touraj Taheri, James S. Wilmott, Georgina V. Long, Richard A Scolyer, Martin Batstone, William C. Dougall, Robert J. Johnston, Ludovic Martinet, Mark J. Smyth, Tobias Bald
A. Lepletier de Oliveira, Jason Madore, Jake S. O’Donnell, Rebecca L. Johnston, Melissa Eastgate, Domenico Mallardo, Paolo A. Ascierto, Daniela Massi, Barbara Merelli, Mario Mandalà, James S. Wilmott, Tobias Bald, J. C. A. Stagg, Bertrand Routy, Georgina V. Long, Richard A Scolyer, Nicola Waddell, William C. Dougall, Michele W.L. Teng, Mark J. Smyth
Ailin Lepletier, Jason Madore, Jake S. O’Donnell, Rebecca L. Johnston, Xian-Yang Li, Elizabeth S. McDonald, Elizabeth Ahern, Anna Kuchel, Melissa Eastgate, Sally‐Ann Pearson, Domenico Mallardo, Paolo A. Ascierto, Daniela Massi, Barbara Merelli, Mario Mandalà, James S. Wilmott, Alexander M. Menzies, Charles Leduc, J. C. A. Stagg, Bertrand Routy, Georgina V. Long, Richard A Scolyer, Tobias Bald,
Mélanie Tichet, Stephan Wullschleger, Agnieszka Chryplewicz, Nadine Fournier, Rachel Marcone, Annamaria Kauzlaric, Krisztián Homicskó, Laura Codarri Deak, Pablo Umaña, Christian Klein, Douglas Hanahan
Discussion(0)
No comments yet. Be the first to comment.